Clinical Trial

Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery

Study acronym: MD FluNCS
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The investigation will establish biological plausibility and infrastructure required for a multisite clinical trial evaluating the re-purposing of fluvoxamine to mitigate postoperative delirium risk in geriatric patients undergoing non-cardiac non-intracranial surgery.
Trial Details
NCT Number NCT06969287
Lead Sponsor Washington University School of Medicine
Collaborators: National Institute on Aging (NIA)
Conditions Delirium, Surgery-Complications
Enrollment 46 participants
Start Date 2026-04-06
Primary Completion 2027-04-01 (estimated)
Study Completion 2028-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-29